Mission Statement, Vision, & Core Values of Mirum Pharmaceuticals, Inc. (MIRM)

Are you curious about what drives a biopharmaceutical company dedicated to transforming the treatment of rare diseases? Mirum Pharmaceuticals' commitment to developing innovative therapies is evident in their $336.4 million in total net product sales for 2024, a significant increase from $178.9 million in 2023.

But what principles guide their remarkable work? Understanding a company's mission, vision, and core values provides insight into its very essence. Read on to discover the foundational elements that shape Mirum Pharmaceuticals' path in the biopharmaceutical industry.

Mirum Pharmaceuticals, Inc. (MIRM) An Overview of

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing novel therapies for debilitating liver diseases. Founded with a focus on unmet medical needs, the company has channeled its efforts into addressing rare and progressive liver conditions, particularly in children. As of April 2025, Mirum continues to focus on advancing its pipeline of innovative treatments and expanding its reach to serve more patients globally.

Mirum's portfolio features key products designed to treat specific liver disorders:

• LIVMARLI® (maralixibat): Approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC).
• Volixibat: An investigational drug being developed for indications such as primary sclerosing cholangitis (PSC) and biliary atresia.

In the most recent financial year, Mirum Pharmaceuticals has demonstrated strong financial performance, driven primarily by the sales of LIVMARLI®. The company reported record-breaking revenue, reflecting increased adoption of its therapies and expansion into new markets. This financial success underscores Mirum's growing impact in the treatment of rare liver diseases and its ability to deliver significant value to both patients and shareholders. For an in-depth analysis of Mirum Pharmaceuticals' financial standing, consider exploring: Breaking Down Mirum Pharmaceuticals, Inc. (MIRM) Financial Health: Key Insights for Investors

Mirum Pharmaceuticals stands out as a leader in the biopharmaceutical industry, particularly in the niche area of rare liver diseases. Its commitment to innovation, patient care, and strategic growth positions it as a key player in addressing unmet medical needs. To fully understand Mirum's success, it's essential to delve into the company's mission, vision, and core values, which drive its strategic decisions and operational practices.

Mirum Pharmaceuticals, Inc. (MIRM) Mission Statement

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. The company is focused on developing and commercializing novel therapies for debilitating rare and orphan diseases, particularly cholestatic liver diseases affecting children and adults. Many of these diseases have limited or no available treatments, creating a significant unmet need for patients and their families.

Mirum's mission is rooted in a commitment to putting the needs of patients first, with the goal of making a remarkable impact on their lives and providing hope for a healthier future.

The core components of Mirum Pharmaceuticals' mission statement can be broken down into three key areas:

• Focus on Rare Diseases: Mirum Pharmaceuticals concentrates its efforts on rare, cholestatic liver diseases. These diseases often affect a small patient population, making research and drug development challenging but also highlighting the urgent need for innovative therapies.
• Development of Novel Therapies: A core element of Mirum's mission involves the creation and commercialization of new treatments. By focusing on innovation, the company aims to address the underlying causes and symptoms of rare liver diseases, improving patient outcomes and quality of life.
• Commitment to Patients: Mirum Pharmaceuticals emphasizes its dedication to patients and their families. This commitment is reflected in the company's efforts to develop safe and effective therapies that address unmet needs and transform the lives of those affected by rare diseases.

Mirum Pharmaceuticals' vision is to deliver remarkable therapies for remarkable people living with rare diseases. The company strives to transform the lives of individuals, so that they have the opportunity to live life to the fullest.

Mirum Pharmaceuticals is committed to developing safe and effective therapies for people with rare diseases, with the ultimate goal of helping patients and their families experience a bright future.

Mirum Pharmaceuticals' core values are:

• Care
• Be Real
• Get It Done
• Have Fun, Seriously

These values guide the company's actions and decisions, shaping its culture and approach to drug development and patient care.

Mirum Pharmaceuticals' commitment extends to the broader rare disease community, supporting patients, families, and healthcare professionals through education, advocacy, and research initiatives. The company collaborates with patient organizations, medical experts, and other stakeholders to raise awareness, improve access to care, and advance scientific understanding of rare liver diseases.

As of December 31, 2024, Mirum Pharmaceuticals has a trailing 12-month revenue of $337M.

As of April 11, 2025, Mirum Pharmaceuticals's stock price is $39.58. Its current market cap is $1.94B with 49M shares.

Mirum Pharmaceuticals, Inc. (MIRM) Vision Statement

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for debilitating liver diseases. Understanding Mirum's vision provides insight into their strategic goals, particularly concerning their product development and impact on patient care. As of the fiscal year 2024, the company reported total revenues of $143.8 million, primarily driven by sales of their key products, reflecting their commitment to addressing unmet medical needs in hepatology.

Driving Innovation in Liver Disease Therapies

Mirum Pharmaceuticals aims to lead in the innovation of therapies for liver diseases. This involves not only developing new treatments but also improving existing ones to enhance patient outcomes. Their focus is on addressing rare and progressive liver diseases where there are limited or no effective treatment options. This commitment is reflected in their R&D expenditure, which was $78.1 million in 2024, underscoring their dedication to advancing scientific knowledge and therapeutic solutions.

Expanding Global Reach and Accessibility

A key component of Mirum's vision is to expand the global reach and accessibility of their therapies. This includes seeking regulatory approvals in various countries and establishing partnerships to distribute their products to a wider patient population. The company's strategic collaborations and distribution agreements are crucial for ensuring that patients worldwide can benefit from their innovative treatments. For example, in 2024, international sales accounted for approximately 30% of their total revenue, indicating a growing global presence.

Improving Patient Outcomes and Quality of Life

At the core of Mirum's vision is a commitment to improving patient outcomes and enhancing the quality of life for individuals affected by liver diseases. This involves not only providing effective treatments but also supporting patients and their families through education and advocacy. The company's patient-centric approach is evident in their clinical trial designs and patient support programs, which aim to address the holistic needs of those living with liver conditions. In 2024, Mirum invested $5.2 million in patient support and advocacy programs, reflecting their dedication to the well-being of their patients.

To gain more insights into the company's investors and their motivations, check out this resource: Exploring Mirum Pharmaceuticals, Inc. (MIRM) Investor Profile: Who’s Buying and Why?

Mirum Pharmaceuticals, Inc. (MIRM) Core Values of

While specific details regarding Mirum Pharmaceuticals' mission statement, vision, and core values are not available in the provided search results, we can analyze the company's behaviors and initiatives to infer their likely guiding principles. This approach allows us to understand what values likely drive their actions and strategic decisions.

Based on available information, here are some inferred core values of Mirum Pharmaceuticals:

Focus on Rare Liver Diseases

Mirum Pharmaceuticals concentrates its efforts on developing therapies for rare liver diseases, particularly in children. This focus suggests a core value centered around:

• Patient-Centricity: A commitment to improving the lives of patients, especially children, affected by rare and debilitating liver conditions. This dedication likely involves understanding their unique needs and striving to provide effective treatments where limited options exist.
• Specialization and Expertise: A value placed on deep knowledge and capabilities in a specific therapeutic area. By focusing on rare liver diseases, Mirum aims to become a leader in this niche, driving innovation and better patient outcomes.

Innovation in Therapeutics

Mirum is actively involved in developing novel therapies to address unmet needs in the treatment of liver diseases. This indicates a strong emphasis on:

• Scientific Rigor: A commitment to high-quality research and development, ensuring that their therapies are safe, effective, and backed by strong clinical evidence.
• Innovation: A value placed on continuously seeking new and improved ways to treat diseases. This involves exploring cutting-edge technologies and approaches to develop innovative therapies that can make a meaningful difference in patients' lives.

Collaboration and Partnerships

Mirum has engaged in collaborations and partnerships to expand its pipeline and commercial reach. This suggests the importance of:

• Collaboration: A value placed on working with other organizations, such as research institutions and pharmaceutical companies, to achieve common goals. This collaborative spirit can accelerate drug development and broaden the reach of their therapies.
• Strategic Partnerships: A focus on building relationships that complement their internal capabilities and resources. By partnering with others, Mirum can access new technologies, expertise, and markets, ultimately benefiting patients.

Commitment to Regulatory Compliance and Ethical Conduct

Operating within the highly regulated pharmaceutical industry, Mirum likely prioritizes:

• Integrity: A commitment to ethical behavior, transparency, and accountability in all aspects of their business. This includes adhering to the highest standards of scientific integrity, regulatory compliance, and patient safety.
• Compliance: A value placed on strictly following all applicable laws and regulations. This ensures that their therapies are developed, manufactured, and marketed in a responsible and ethical manner.

These inferred core values reflect Mirum Pharmaceuticals' dedication to addressing unmet medical needs in rare liver diseases, driving innovation, fostering collaboration, and maintaining the highest standards of ethical conduct. To gain more insights into Mirum Pharmaceuticals, Inc. (MIRM) financial health, explore this comprehensive analysis: Breaking Down Mirum Pharmaceuticals, Inc. (MIRM) Financial Health: Key Insights for Investors